Romania Contraceptive Devices Market Report 2022 to 2030

Romania Contraceptive Devices Market Analysis

$ 3999

Romania's Contraceptive Devices Market is expected to witness growth from $37 Mn in 2022 to $71 Mn in 2030 with a CAGR of 8.25% for the forecasted year 2022-30. In Romania, there is a rising acceptance of family planning and contraception, which has increased the demand for contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Italtrade & Co S.R.L, Adar Unic Solutions SRL, Organon Heist, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10ROMD005 CATEGORY: Medical Devices GEOGRAPHY: Romania AUTHOR: Jigyasu Bhandari

Buy Now

Romania Contraceptive Devices Healthcare Market Executive Analysis

Romania's Contraceptive Devices Market is expected to witness growth from $37 Mn in 2022 to $71 Mn in 2030 with a CAGR of 8.25% for the forecasted year 2022-30. Romania's current health expenditures will make up 6.69% of GDP in 2023. In 2019, Romania, the member nation with the lowest spending, spent only $923 per person on healthcare, or less than one-third of the EU average. The lowest health-related GDP share, which is also the lowest, of 6.3% is significantly higher than the EU average of 9.9%.

In Romania, there were 54 maternal deaths per 100,000 live births in 2021. The prevalence of sexually transmitted infections is high in Romania. In 2022, Romania had an incidence rate of 578 chlamydia infections per 100,000 people, 259 gonorrhea cases per 100,000 people, and 2 syphilis cases per 100,000 people. Young persons between the ages of 15 and 24 were found to have the highest incidence of STIs. A crucial tool for family planning and reproductive health is the contraceptive method. Contraceptive methods are widely accessible and utilized by a sizeable section of the population in Romania. Utilizing contraceptive methods, couples can plan their family size and spacing while also preventing unexpected births. This may benefit a family's social and economic well-being as well as the health of the mother and kid. In the long run, contraceptive methods save money since they can lessen the need for more expensive medical procedures like pregnancy and abortion.

Romania Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Romania, there is a rising acceptance of family planning and contraception, which has increased demand for contraceptive methods. The provision of free or heavily discounted contraception is one of the steps the Romanian government has put into place to promote access to family planning services. This has fueled market expansion. By giving consumers more practical and efficient options, the development of new and inventive contraceptive methods—such as hormonal and long-acting reversible methods—has fueled market expansion. The usage of contraception has increased and fertility rates have decreased in Romania, which has increased demand for contraceptive methods. Men are becoming more aware of the value of contraception, and this increased awareness has resulted in a rise in the usage of male contraceptives such as condoms and vasectomies.

Market Restraints

The use of contraception may be discouraged in Romania due to certain cultural and religious issues, which may restrict market expansion. People may be discouraged from using or even considering contraceptive methods due to stigma and false information regarding contraception. Few major companies dominate the Romanian market for contraceptive devices, which restricts the availability of a wide variety of products and may have an impact on market expansion. Although the government offers free or heavily discounted contraceptives, some models, such as long-acting reversible contraceptives, might be pricey for users, which can restrain market expansion.

Competitive Landscape

Key Players

Italtrade & Co S.R.L. (RO)
Adar Unic Solutions SRL (RO)
Mylan Laboratories
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The National Agency for Medicines and Medical Devices (NAMMD), which is in charge of the evaluation and authorization of medical devices, including contraceptive devices, is in charge of overseeing the regulatory environment for contraceptive devices in Romania. The NAMMD must approve and all contraceptive products supplied in Romania must abide by the medical device laws of the European Union. The National Health Insurance Fund (NHIF), which establishes prices based on a cost-effectiveness analysis and reimburses for selected contraceptive devices through its reimbursement programme, controls the pricing and reimbursement of contraceptive devices in Romania. The design, development, and manufacture of contraceptive devices must comply with strict quality requirements, including ISO 13485 certification. Before their goods may be approved for sale in Romania, contraceptive device manufacturers are required to undergo clinical trials to demonstrate the safety and efficacy of their products.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.